These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9631885)

  • 1. Cardiovascular preparticipation screening of competitive athletes: addendum: an addendum to a statement for health professionals from the Sudden Death Committee (Council on Clinical Cardiology) and the Congenital Cardiac Defects Committee (Council on Cardiovascular Disease in the Young), American Heart Association.
    Maron BJ; Thompson PD; Puffer JC; McGrew CA; Strong WB; Douglas PS; Clark LT; Mitten MJ; Crawford MD; Atkins DL; Driscoll DJ; Epstein AE
    Circulation; 1998 Jun; 97(22):2294. PubMed ID: 9631885
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association.
    Maron BJ; Thompson PD; Puffer JC; McGrew CA; Strong WB; Douglas PS; Clark LT; Mitten MJ; Crawford MH; Atkins DL; Driscoll DJ; Epstein AE
    Circulation; 1996 Aug; 94(4):850-6. PubMed ID: 8772711
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
    Maron BJ; Thompson PD; Ackerman MJ; Balady G; Berger S; Cohen D; Dimeff R; Douglas PS; Glover DW; Hutter AM; Krauss MD; Maron MS; Mitten MJ; Roberts WO; Puffer JC;
    Circulation; 2007 Mar; 115(12):1643-455. PubMed ID: 17353433
    [No Abstract]   [Full Text] [Related]  

  • 4. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Levine BD; Washington RL; Baggish AL; Kovacs RJ; Maron MS;
    Circulation; 2015 Dec; 132(22):e267-72. PubMed ID: 26527714
    [No Abstract]   [Full Text] [Related]  

  • 5. Profile of preparticipation cardiovascular screening for high school athletes.
    Glover DW; Maron BJ
    JAMA; 1998 Jun; 279(22):1817-9. PubMed ID: 9628714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular evaluation of the young athlete.
    Luckstead EF
    Adolesc Med; 1998 Oct; 9(3):441-55, v. PubMed ID: 9928459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for evaluation and management of common congenital cardiac problems in infants, children, and adolescents. A statement for healthcare professionals from the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young, American Heart Association.
    Driscoll D; Allen HD; Atkins DL; Brenner J; Dunnigan A; Franklin W; Gutgesell HP; Herndon P; Shaddy RE; Taubert KA
    Circulation; 1994 Oct; 90(4):2180-8. PubMed ID: 7923709
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular screening of student athletes.
    Lyznicki JM; Nielsen NH; Schneider JF
    Am Fam Physician; 2000 Aug; 62(4):765-74. PubMed ID: 10969856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Levine BD; Washington RL; Baggish AL; Kovacs RJ; Maron MS
    J Am Coll Cardiol; 2015 Dec; 66(21):2356-2361. PubMed ID: 26542659
    [No Abstract]   [Full Text] [Related]  

  • 10. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles.
    Maron BJ; Shirani J; Poliac LC; Mathenge R; Roberts WC; Mueller FO
    JAMA; 1996 Jul; 276(3):199-204. PubMed ID: 8667563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current Evidence, Knowledge Gaps, Recommendations, and Future Directions.
    Drezner JA; OʼConnor FG; Harmon KG; Fields KB; Asplund CA; Asif IM; Price DE; Dimeff RJ; Bernhardt DT; Roberts WO
    Clin J Sport Med; 2016 Sep; 26(5):347-61. PubMed ID: 27598018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
    Corrado D; Pelliccia A; Bjørnstad HH; Vanhees L; Biffi A; Borjesson M; Panhuyzen-Goedkoop N; Deligiannis A; Solberg E; Dugmore D; Mellwig KP; Assanelli D; Delise P; van-Buuren F; Anastasakis A; Heidbuchel H; Hoffmann E; Fagard R; Priori SG; Basso C; Arbustini E; Blomstrom-Lundqvist C; McKenna WJ; Thiene G;
    Eur Heart J; 2005 Mar; 26(5):516-24. PubMed ID: 15689345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the AHA scientific statement concerning cardiovascular preparticipation screening of competitive athletes.
    McGrew CA
    Med Sci Sports Exerc; 1998 Oct; 30(10 Suppl):S351-3. PubMed ID: 9789861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding sports preparticipation cardiovascular screening recommendations.
    Bultas MW
    NASN Sch Nurse; 2012 Nov; 27(6):318-22. PubMed ID: 23193725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparticipation Screening of Young Athletes: Identifying Cardiovascular Disease.
    Lammlein KP; Stoddard JM; O'Connor FG
    Prim Care; 2018 Mar; 45(1):95-107. PubMed ID: 29406947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current Evidence, Knowledge Gaps, Recommendations and Future Directions.
    Drezner JA; O'Connor FG; Harmon KG; Fields KB; Asplund CA; Asif IM; Price DE; Dimeff RJ; Bernhardt DT; Roberts WO
    Curr Sports Med Rep; 2016; 15(5):359-75. PubMed ID: 27618246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Eligibility to competitive and non-competitive sports activity in Cardiology].
    Delise P
    G Ital Cardiol (Rome); 2015 Feb; 16(2):88-91. PubMed ID: 25805092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current evidence, knowledge gaps, recommendations and future directions.
    Drezner JA; O'Connor FG; Harmon KG; Fields KB; Asplund CA; Asif IM; Price DE; Dimeff RJ; Bernhardt DT; Roberts WO
    Br J Sports Med; 2017 Feb; 51(3):153-167. PubMed ID: 27660369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on cardiovascular screening: can we prevent sudden cardiac death in adolescent athletes?
    Patel DR; Luckstead EF
    Adolesc Med State Art Rev; 2013 Apr; 24(1):225-41, xiv. PubMed ID: 23705527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preparticipation sports examination. Cardiovascular considerations for screening.
    Fahrenbach MC; Thompson PD
    Cardiol Clin; 1992 May; 10(2):319-28. PubMed ID: 1576617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.